Journal of Hepatocellular Carcinoma
Volume 11, 2024 - Issue
Open access
83
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization
Baogen Zhang1 Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, People’s Republic of China
https://orcid.org/0000-0001-6110-7408View further author information
Biqing Huang2 Department of Interventional Radiology and Vascular Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, People’s Republic of ChinaView further author information
, Fan Yang3 Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, People’s Republic of ChinaView further author information
, Jiandong Yang1 Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, People’s Republic of ChinaView further author information
, Man Kong1 Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, People’s Republic of ChinaView further author information
, Jing Wang1 Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, People’s Republic of ChinaView further author information
, Yaoxian Xiang1 Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, People’s Republic of ChinaView further author information
, Kangjie Wang1 Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, People’s Republic of China
https://orcid.org/0009-0002-7063-5610View further author information
Ruchen Peng4 Department of Medical Imaging, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, People’s Republic of ChinaView further author information
, Kun Yang4 Department of Medical Imaging, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, People’s Republic of ChinaView further author information
, Chao An5 Department of Minimal Invasive Intervention, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative, Innovation Center for Cancer Medicine, Guangzhou, 510060, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-1096-4183View further author information
Dong Yan1 Department of Oncology, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, 101149, People’s Republic of ChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 651-663
|
Received 31 Jan 2024, Accepted 20 Mar 2024, Published online: 27 Mar 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.